Found 17 matching trials
Ruxolitinib, Human Chorionic Gonadotropin (uhCG/EGF), and Dose De-escalated Corticosteroids PHASE1 This multi-center center phase I/II study to establish the lowest possible ...
Show More Location
Masonic Cancer Center at University of Minnesota
Learn More & Join Trial
Efficacy and Safety of Anti-CD25 rhMAb in the Treatment of Steroid-Refractory cGVHD PHASE4 The study plan aims to include patients who have been diagnosed with steroi...
Show More Location
Multiple Locations
Learn More & Join Trial
Ruxolitinib Phosphate or Dasatinib With Chemotherapy in Treating Patients With Relapsed or Refractory Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia PHASE2 This phase II trial studies the side effects and best dose of ruxolitinib p...
Show More Location
M D Anderson Cancer Center
Learn More & Join Trial
ABL/JAK Inhibitors With Chemotherapy and Venetoclax for Ph-like ALL NA This open-label, non-randomized, phase II exploratory study aims to evaluat...
Show More Location
Blood diseases hospital
Learn More & Join Trial
A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia PHASE2 This is a nonrandomized study of ruxolitinib in combination with a standard...
Show More Location
The Childrens Hospital of Alabama
Learn More & Join Trial
Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies PHASE1 The purpose of the Study is to select a dose and assess the safety and tole...
Show More Location
University of Alabama
Learn More & Join Trial
Ruxolitinib in Combination With CHOP Chemotherapy for the Treatment of Untreated Nodal T-Follicular Helper Cell Lymphomas PHASE1 This phase I trial tests the safety, side effects and best dose of ruxoliti...
Show More Location
City of Hope Medical Center
Learn More & Join Trial
A Study of Ruxolitinib in Combination With Corticosteroids for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease (REACH-1) PHASE2 The purpose of this study was to assess the efficacy of ruxolitinib in comb...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Evaluate the Safety and Efficacy of Axatilimab in Combination With Ruxolitinib in Participants With Newly Diagnosed Chronic Graft-Versus-Host Disease PHASE2 This study will be conducted to determine the preliminary efficacy of axati...
Show More Status
Active Not Recruiting
Location
Mayo Clinic Hospital
Learn More & Join Trial
Zanubrutinib Combined With Rituximab in the Treatment of Secondary HLH in B-cell Lymphoma PHASE4 For patients who met the inclusion criteria, treatment regimens were admini...
Show More Location
The First Affiliated Hospital of Soochow University
Learn More & Join Trial